triazinate has been researched along with Breast Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Colsky, J; Cummings, FJ; Gelman, R; Israel, L; Kuperminc, M; Skeel, RT; Tormey, D | 1 |
| Ahmann, DL; Edmonson, JH; Ingle, JN; Kvols, LK; Nichols, WC; O'Connell, MJ; Rubin, J | 1 |
2 trial(s) available for triazinate and Breast Neoplasms
| Article | Year |
|---|---|
Phase II trials of Baker's antifol, bleomycin, CCNU, streptozotocin, tilorone, and 5-fluorodeoxyuridine plus arabinosyl cytosine in metastatic breast cancer.
Topics: Antineoplastic Agents; Bleomycin; Breast Neoplasms; Cytarabine; Drug Evaluation; Drug Therapy, Combination; Female; Floxuridine; Humans; Lomustine; Probability; Streptozocin; Tilorone; Triazines | 1981 |
Phase II study of triazinate and pyrazofurin in patients with advanced breast cancer previously exposed to cytotoxic chemotherapy.
Topics: Adult; Aged; Amides; Antibiotics, Antineoplastic; Breast Neoplasms; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Female; Folic Acid Antagonists; Humans; Infusions, Parenteral; Middle Aged; Pyrazoles; Ribonucleosides; Ribose; Triazines | 1978 |